Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

C-Myc inhibitor 9

C-Myc inhibitor 9 (compound 332) is a c-Myc inhibitor with an logEC50 of ≥6. c-Myc inhibitor 9 inhibits tumor growth in nude mouse models. c-Myc inhibitor 9 can be used for cancer research[1].

Product Specifications

CAS Number

[2799717-96-5]

UNSPSC

12352005

Target

C-Myc

Type

Reference compound

Related Pathways

Apoptosis

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/c-myc-inhibitor-9.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CC=C2C(SC3=NC(C4=CC=C(C5(CC5)N)C=C4)=CN32)=C1)NCCCN6CCCCC6

Molecular Formula

C27H31N5OS

Molecular Weight

473.63

References & Citations

[1]Sheppard, David William, et al. Preparation of heteroaryl compounds as c-MYC mRNA translation modulators and uses thereof in the treatment of cancer. WO2022150316. 2022.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

SEC16B  polyclonal antibody
BS75899 50ul

SEC16B polyclonal antibody

Sign In for Pricing
View Details
TPGS1 Protein Vector (Rat) (pPM-C-His)
PV312485 500 ng

TPGS1 Protein Vector (Rat) (pPM-C-His)

Sign In for Pricing
View Details
Siglec-7 Protein, Human, Recombinant (aa 1-353, His)
MF-0137200-01 5 µg

Siglec-7 Protein, Human, Recombinant (aa 1-353, His)

Sign In for Pricing
View Details
Siglec-7 Protein, Human, Recombinant (aa 1-353, His)
MF-0137200-02 10 µg

Siglec-7 Protein, Human, Recombinant (aa 1-353, His)

Sign In for Pricing
View Details
Siglec-7 Protein, Human, Recombinant (aa 1-353, His)
MF-0137200-03 20 µg

Siglec-7 Protein, Human, Recombinant (aa 1-353, His)

Sign In for Pricing
View Details
Siglec-7 Protein, Human, Recombinant (aa 1-353, His)
MF-0137200-04 50 µg

Siglec-7 Protein, Human, Recombinant (aa 1-353, His)

Sign In for Pricing
View Details